ADAM8
Disintegrin and metalloproteinase domain-containing protein 8
Also known as: ADAM8_HUMAN, CD156, CD156A, MS2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78325
- Gene
- ADAM8
- Ensembl
- ENSG00000151651
- Chromosome
- 10
- Canonical length
- 824 aa
- Protein class
- CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene may be involved in cell adhesion during neurodegeneration, and it is thought to be a target for allergic respiratory diseases, including asthma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2009]
Canonical amino-acid sequenceUniProt
824 residues, UniProt reviewed canonical sequence.
>P78325|ADAM8
1 MRGLGLWLLG AMMLPAIAPS RPWALMEQYE VVLPWRLPGP RVRRALPSHL GLHPERVSYV
61 LGATGHNFTL HLRKNRDLLG SGYTETYTAA NGSEVTEQPR GQDHCFYQGH VEGYPDSAAS
121 LSTCAGLRGF FQVGSDLHLI EPLDEGGEGG RHAVYQAEHL LQTAGTCGVS DDSLGSLLGP
181 RTAAVFRPRP GDSLPSRETR YVELYVVVDN AEFQMLGSEA AVRHRVLEVV NHVDKLYQKL
241 NFRVVLVGLE IWNSQDRFHV SPDPSVTLEN LLTWQARQRT RRHLHDNVQL ITGVDFTGTT
301 VGFARVSAMC SHSSGAVNQD HSKNPVGVAC TMAHEMGHNL GMDHDENVQG CRCQERFEAG
361 RCIMAGSIGS SFPRMFSDCS QAYLESFLER PQSVCLANAP DLSHLVGGPV CGNLFVERGE
421 QCDCGPPEDC RNRCCNSTTC QLAEGAQCAH GTCCQECKVK PAGELCRPKK DMCDLEEFCD
481 GRHPECPEDA FQENGTPCSG GYCYNGACPT LAQQCQAFWG PGGQAAEESC FSYDILPGCK
541 ASRYRADMCG VLQCKGGQQP LGRAICIVDV CHALTTEDGT AYEPVPEGTR CGPEKVCWKG
601 RCQDLHVYRS SNCSAQCHNH GVCNHKQECH CHAGWAPPHC AKLLTEVHAA SGSLPVFVVV
661 VLVLLAVVLV TLAGIIVYRK ARSRILSRNV APKTTMGRSN PLFHQAASRV PAKGGAPAPS
721 RGPQELVPTT HPGQPARHPA SSVALKRPPP APPVTVSSPP FPVPVYTRQA PKQVIKPTFA
781 PPVPPVKPGA GAANPGPAEG AVGPKVALKP PIQRKQGAGA PTAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADAM8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 65 nTPM
- spleen: 47 nTPM
- lung: 21 nTPM
- appendix: 21 nTPM
- urinary bladder: 11 nTPM
- lymph node: 11 nTPM
Single-cell type
- neutrophils: 326 nCPM
- extravillous trophoblasts: 137 nCPM
- cdc: 77 nCPM
- nk-cells: 54 nCPM
- mast cells: 47 nCPM
- neutrophil progenitors: 44 nCPM
Immune cell
- eosinophil: 259 nTPM
- neutrophil: 140 nTPM
- basophil: 108 nTPM
- myeloid DC: 37 nTPM
- total PBMC: 25 nTPM
- classical monocyte: 25 nTPM
Brain region
- cerebral cortex: 44 nTPM
- thalamus: 13 nTPM
- pons: 9.4 nTPM
- medulla oblongata: 7 nTPM
- white matter: 6.9 nTPM
- basal ganglia: 5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- canonical NF-kappaB signal transduction
- cell morphogenesis
- cell-cell adhesion
- cellular response to hypoxia
- extracellular matrix disassembly
- inflammatory response
- leukocyte migration involved in inflammatory response
- lymphocyte chemotaxis
- negative regulation of neuron apoptotic process
- positive regulation of acute inflammatory response
- positive regulation of bone resorption
- positive regulation of cell adhesion
- positive regulation of cellular extravasation
- positive regulation of eosinophil migration
- positive regulation of epithelial to mesenchymal transition
- positive regulation of innate immune response
- positive regulation of MAPK cascade
- positive regulation of membrane protein ectodomain proteolysis
- positive regulation of neutrophil extravasation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein processing
- positive regulation of protein secretion
- positive regulation of T cell differentiation in thymus
- positive regulation of thymocyte apoptotic process
- positive regulation of tumor necrosis factor (ligand) superfamily member 11 production
- proteolysis
- regulation of cell-cell adhesion
- signal release
- positive regulation of fibronectin-dependent thymocyte migration
Molecular functions
- calcium ion binding
- cell adhesion molecule binding
- immunoglobulin receptor binding
- metalloendopeptidase activity
- metallopeptidase activity
- serine-type endopeptidase activity
- tumor necrosis factor receptor superfamily binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Peptidase M12B, ADAM/reprolysin
- Disintegrin domain
- Peptidase M12B, propeptide
- ADAM, cysteine-rich domain
- Disintegrin, conserved site
- Metallopeptidase, catalytic domain superfamily
- Reprolysin domain, adamalysin-type
- Disintegrin domain superfamily
- Disintegrin
- Reprolysin (M12B) family zinc metalloprotease
- Reprolysin family propeptide
- ADAM cysteine-rich
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADAM8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- FST3
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADAM8 as an antibody target. Whether an autoantibody or antibody against ADAM8 could matter depends on whether native ADAM8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADAM8 is annotated at the cell surface, where native ADAM8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADAM8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...